Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Coronavirus Report – Part 27: Pandemic Sees Clinical Trials for New Drugs Suspended, Postponed

Filed Under: Coronavirus, Pharma Tagged With: , , , , , , , , ,

Development of new drugs to treat diseases other than the novel coronavirus looks set to be delayed as the outbreak…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Coronavirus Report: Part 24 – Survey Reveals 12 Japanese Pharmaceutical Firms Working to Develop CuresCoronavirus Report: Part 24 – Survey Reveals 12…
Anaeropharma Makes Progress With US Clinical Trials of New Anti-Cancer DrugAnaeropharma Makes Progress With US Clinical Trials…
Nippon Shinyaku Targets 2019 Approval for New Muscular Dystrophy TreatmentNippon Shinyaku Targets 2019 Approval for New…
Coronavirus Report: Part 13 – Japanese Companies Start to Develop Vaccines, TreatmentsCoronavirus Report: Part 13 – Japanese Companies…
LSI Medience to Launch Cancer Drug Discovery Support Service Using Avatar MiceLSI Medience to Launch Cancer Drug Discovery Support…
Sumitomo Dainippon Pharma Targets GMP-Based Mass Production of Cellular MedicineSumitomo Dainippon Pharma Targets GMP-Based Mass…